Halberd Corporation 2020 Year End CEO Letter
JACKSON CENTER, PA / ACCESSWIRE / January 4, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC...
Year: 2021
EHNAC Announces Finalized 2021 Accreditation Criteria Versions for All Accreditation Programs
Important updates include new program criteria designed to help payers and providers meet CMS Interoperability and Patient Access final rule...
ATEC to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
CARLSBAD, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions...
Milestone Scientific Inc. Announces Entrée into the Nationally Recognized University of Texas Medical Branch at Galveston with its CompuFlo Disposables
Milestone’s FDA approved CompuFlo and CathCheck instruments and disposables provide significant safety and economic benefitsROSELAND, N.J., Jan. 04, 2021 (GLOBE...
Positive Signals for Endoscopic and Histologic Response in Patients with Crohn’s Disease Treated with Qu Biologics’ QBECO
VANCOUVER, British Columbia, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site...
Resonant’s Intellectual Property Portfolio Surpasses 300 Issued and Pending Patents
Company’s Recent Patent Portfolio Focused on 5G XBAR® TechnologyAUSTIN, Texas, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN),...
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO
CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to...
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Growth Conference
WARSAW, Ind., Jan. 04, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq:KIDS), a company focused exclusively on...
Align Technology to Announce Fourth Quarter and 2020 Results on February 3, 2021
SAN JOSE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will...
Bellerophon to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
WARREN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Chinook Therapeutics to Present at Upcoming Investor Conferences
VANCOUVER, British Columbia and SEATTLE, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused...
Assure Holdings Announces Filing of S-1 Resale Registration Statement
DENVER, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH) announces that...
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
Dr. Kupiec will leverage three decades of drug development experience at Pfizer, Sanofi and Ciba-Geigy to lead the Company’s Phase...
Zosano Pharma to Present at the H.C. Wainwright Virtual BioConnect Conference
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its...
Selecta Biosciences to Participate in the H.C. Wainwright BioConnect 2021 Conference
WATERTOWN, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Celldex Appoints Freddy A. Jimenez, Esq. as Senior Vice President and General Counsel
HAMPTON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced the promotion of Freddy A. Jimenez,...
RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro...
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January
NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing...
89bio to Participate in the H.C. Wainwright BioConnect 2021 Conference
SAN FRANCISCO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...